Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoya Fujino

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Respirology (Carlton, Vic.)|March 25, 2026
Novel Therapeutics for Chronic Obstructive Pulmonary Disease: From Empirical Bronchodilation to Precision MedicineNaoya Fujino, Hisatoshi Sugiura
Diagnostics (Basel, Switzerland)|June 2, 2021
ACO (Asthma-COPD Overlap) Is Independent from COPD, a Case in Favor: A Systematic ReviewNaoya Fujino, Hisatoshi Sugiura
Inflammation and Regeneration|December 21, 2017
Inflammatory responses in the initiation of lung repair and regeneration: their role in stimulating lung resident stem cellsMitsuhiro Yamada, Naoya Fujino, Masakazu Ichinose
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 30, 2017
Phenotypic screening identifies Axl kinase as a negative regulator of an alveolar epithelial cell phenotypeNaoya Fujino, Hiroshi Kubo, Rose A Maciewicz
Respirology (Carlton, Vic.)|August 8, 2009
Successful treatment of refractory bronchioloalveolar carcinoma with S-1 (oral fluoropyrimidine)Seiichi Kobayashi, Naoya Fujino, Satoshi Suzuki, et al.
Respiratory Investigation|April 12, 2026
Genetic susceptibility, terminal bronchiole pathology, and inflammation: An integrated mechanisms of the pathogenic process in chronic obstructive pulmonary diseaseNaoya Fujino, Takuya Saito, Mitsuhiro Yamada, et al.
Respiratory Investigation|April 10, 2024
Treatment with systemic corticosteroid versus placebo for exacerbations of COPD: A systematic review and meta-analysisAkira Koarai, Mitsuhiro Yamada, Tomohiro Ichikawa, et al.
Respiratory Research|June 22, 2021
Triple versus LAMA/LABA combination therapy for patients with COPD: a systematic review and meta-analysisAkira Koarai, Mitsuhiro Yamada, Tomohiro Ichikawa, et al.
Respiratory Investigation|June 9, 2021
Triple versus LAMA/LABA combination therapy for Japanese patients with COPD: A systematic review and meta-analysisAkira Koarai, Mitsuhiro Yamada, Tomohiro Ichikawa, et al.
BMC Pulmonary Medicine|May 1, 2020
Treatment with LABA versus LAMA for stable COPD: a systematic review and meta-analysisAkira Koarai, Hisatoshi Sugiura, Mitsuhiro Yamada, et al.
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Respirology (Carlton, Vic.)|March 25, 2026
Novel Therapeutics for Chronic Obstructive Pulmonary Disease: From Empirical Bronchodilation to Precision MedicineNaoya Fujino, Hisatoshi Sugiura
Diagnostics (Basel, Switzerland)|June 2, 2021
ACO (Asthma-COPD Overlap) Is Independent from COPD, a Case in Favor: A Systematic ReviewNaoya Fujino, Hisatoshi Sugiura
Inflammation and Regeneration|December 21, 2017
Inflammatory responses in the initiation of lung repair and regeneration: their role in stimulating lung resident stem cellsMitsuhiro Yamada, Naoya Fujino, Masakazu Ichinose
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 30, 2017
Phenotypic screening identifies Axl kinase as a negative regulator of an alveolar epithelial cell phenotypeNaoya Fujino, Hiroshi Kubo, Rose A Maciewicz
Respirology (Carlton, Vic.)|August 8, 2009
Successful treatment of refractory bronchioloalveolar carcinoma with S-1 (oral fluoropyrimidine)Seiichi Kobayashi, Naoya Fujino, Satoshi Suzuki, et al.
Respiratory Investigation|April 12, 2026
Genetic susceptibility, terminal bronchiole pathology, and inflammation: An integrated mechanisms of the pathogenic process in chronic obstructive pulmonary diseaseNaoya Fujino, Takuya Saito, Mitsuhiro Yamada, et al.
Respiratory Investigation|April 10, 2024
Treatment with systemic corticosteroid versus placebo for exacerbations of COPD: A systematic review and meta-analysisAkira Koarai, Mitsuhiro Yamada, Tomohiro Ichikawa, et al.
Respiratory Research|June 22, 2021
Triple versus LAMA/LABA combination therapy for patients with COPD: a systematic review and meta-analysisAkira Koarai, Mitsuhiro Yamada, Tomohiro Ichikawa, et al.
Respiratory Investigation|June 9, 2021
Triple versus LAMA/LABA combination therapy for Japanese patients with COPD: A systematic review and meta-analysisAkira Koarai, Mitsuhiro Yamada, Tomohiro Ichikawa, et al.
BMC Pulmonary Medicine|May 1, 2020
Treatment with LABA versus LAMA for stable COPD: a systematic review and meta-analysisAkira Koarai, Hisatoshi Sugiura, Mitsuhiro Yamada, et al.
Pageof 7